CUSIP: 286221106
Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,481,626
-
Share change
-
+1,786,471
-
Total reported value
-
$159,436,208
-
Price per share
-
$11.88
-
Number of holders
-
41
-
Value change
-
+$20,513,994
-
Number of buys
-
20
-
Number of sells
-
14
Quarterly Holders Quick Answers
What is CUSIP 286221106?
CUSIP 286221106 identifies EBIO - ELEVEN BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2015
-
Previous quarter:
Q3 2014
Recent filing periods for CUSIP 286221106:
Institutional Holders of ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) as of Q4 2014
As of 31 Dec 2014,
ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,481,626 shares.
The largest 10 holders included
Third Rock Ventures, LLC, Flagship Ventures 2007 General Partner LLC, FMR LLC, Broadfin Capital, LLC, FRANKLIN RESOURCES INC, SABBY MANAGEMENT, LLC, Tekla Capital Management LLC, JPMORGAN CHASE & CO, Redmile Group, LLC, and Point72 Asset Management, L.P..
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.